Press release
At a CAGR of 41.58%, Global Antibody Conjugates Drugs Market is poised to grow during the period 2016-2020: Key Vendors are AbbVie, Ambrx, Agensys etc.
ResearchMoz added Latest Research Report titled " Global Antibody Conjugates Drugs Market 2016-2020 " to it's Large Report database.About Antibody Drug Conjugates
ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tissue.
Antibodies are the proteins produced by B-cells (from bone marrow) in the immune system. These proteins attach to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies that attach to different sites of an antigen. mAbs, complex proteins with high molecular weight, are monospecific as they are the clones of a single parent cell. They are of three types, chimeric, humanized, and fully human, and are often used for therapeutic and diagnostic purposes.
Technavios analysts forecast the global ADCs market to grow at a CAGR of 41.58% during the period 2016-2020.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=700592
Covered in this report
The report covers the present scenario and the growth prospects of the global ADCs market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of ADCs used to treat cancer.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Antibody Drug Conjugates Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Browse more details @ http://www.researchmoz.us/global-antibody-conjugates-drugs-market-2016-2020-report.html
Table of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
Assumptions
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview of ADCs
Antibodies
Evolution of mAb therapeutics
Conjugated mAbs
History
Key components in ADCs
Next-generation ADCs
Advantages
Challenges
Outsourcing of ADCs manufacturing
Emergence of ADCs
Current marketed ADCs
PART 06: Pipeline portfolio
Information on pipeline candidates
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release At a CAGR of 41.58%, Global Antibody Conjugates Drugs Market is poised to grow during the period 2016-2020: Key Vendors are AbbVie, Ambrx, Agensys etc. here
News-ID: 632295 • Views: …
More Releases for ADCs
Monodispersed PEG Linkers Enhance Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. Introducing polyethylene glycol (PEG) linkers between the antibody and drug payload can address this. PEG is hydrophilic, biologically inert, and FDA‐recognized as safe. As a flexible spacer, PEG "shields" the hydrophobic drug, greatly improving ADC solubility and stability. In fact,…
Isolated ADCs Market: Cost, Price, Revenue Analysis Industry Chain Report 2025
Global Isolated ADCs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Isolated ADCs market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Global Info Research's report offers key insights into the recent developments in the global Isolated ADCs market…
Automotive Analog-to-Digital Converters (ADCs) Market Growth in Future Scope 202 …
Global Automotive Analog-to-Digital Converters (ADCs) Market size was valued at USD 2.60 billion in 2022 and is poised to grow from USD 2.73 billion in 2023 to USD 4.07 billion by 2031, at a CAGR of 5.1% during the forecast period (2024-2031).
The Research report on Automotive Analog-to-Digital Converters (ADCs) Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape,…
Creative Biolabs Introduces How ADCs Are Developed - Novel Formats as Examples
Creative Biolabs introduces ADC discovery pipelines for innovative conjugate formats.
New York, USA - June 25, 2024 - ADCs represent a significant leap in targeted cancer therapy by combining the specificity of antibodies with the drugs' potent cytotoxic effects. Creative Biolabs specializes in various ADC conjugation chemistries [https://www.creative-biolabs.com/adc/one-stop-adc-development-service.htm] and provides one-stop ADC development services to meet the unique needs of each research project, especially innovative conjugates that are prevalent across the…
Creative Biolabs: The Way ADCs Are Made Has Changed
Creative Biolabs released information earlier in April about the antibody-drug conjugate service updates.
New York, USA - April 23, 2024 - In February 2024, news featured by Nature highlights antibody-drug conjugates targeting cancer, which have made their way up to the summit, manifesting in multi-billion-dollar deals made across pharmaceutical giants like Pfizer, AbbVie, and Johnson & Johnson.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
"Cancer-targeting ADCs are booming these years," according to a scientist at Creative Biolabs, "exactly…
Application Delivery Controllers (ADCs) Market 2021 | Detailed Report
Application Delivery Controllers (ADCs) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Application Delivery Controllers (ADCs) Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5016520
The report provides a comprehensive analysis of company profiles listed below:
- A10 Networks…